• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

FDA adds Guillain-Barré syndrome warning to GlaxoSmithKline’s shingles vaccine

cafead

Administrator
Staff member
  • cafead   Mar 25, 2021 at 11:02: PM
via The FDA late Wednesday sent out a safety communication to explain that while GlaxoSmithKline’s shingles vaccine Shingrix is a safe vaccine, it’s now added a new warning to the label noting an increased risk of a rare but debilitating disorder known as Guillain-Barré syndrome (GBS).

article source
 

<